Advertisements

Escapin Compuesto

Quick links to important sections

Escapin Compuesto

Advertisements
Advertisements

Method of action: Analgesic, Antiparkinsonian

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Escapin Compuesto

Escapin Compuesto is a pharmaceutical product classified as a Combined Analgesic and Antispasmodic medication, designed specifically to relieve discomfort where pain is complicated by smooth muscle spasms. It is provided as a fixed-dose combination, uniting two distinct active ingredients into a single oral tablet to offer a dual-action approach to symptom relief. The formulation is widely recognized in clinical practice across several regions for its effectiveness in addressing cramp-related pain.


Quick Facts

Property Description
Active Ingredients Acetaminophen, Hyoscine Butylbromide
Form Tablet (Oral)
Pharmacological Class Combined Analgesic and Antispasmodic
General Purpose Relief from painful cramps and spasms
Origin Synthetic/Semi-synthetic combination

What Type of Medicine is Escapin Compuesto?

Escapin Compuesto is primarily a combination product that falls under the dual pharmacological classification of Analgesics (pain relievers) and Antispasmodics (cramp suppressors). This combination is typically used to target pain originating in the internal organs, such as the gastrointestinal or urogenital systems.

The antispasmodic component, Hyoscine Butylbromide, is an anticholinergic agent utilized for its ability to treat abdominal pain caused by cramps. This medicine helps ease discomfort by directly relaxing the involuntary muscles that tighten up during a spasm.

What is Escapin Compuesto Made Of?

The core of Escapin Compuesto consists of two active substances: Acetaminophen (Paracetamol) and Hyoscine Butylbromide (Scopolamine Butylbromide). Acetaminophen is the well-known component responsible for pain reduction and fever-lowering effects. The other key ingredient, Hyoscine Butylbromide, acts directly to relax the smooth muscles of the visceral organs. This specific combination is often seen internationally under similar formulations, confirming its established therapeutic profile.

What is the General Purpose of Escapin Compuesto?

The general purpose of Escapin Compuesto is to offer combined, targeted relief from painful cramps. This medication is valuable because it simultaneously targets the muscle causing the spasm (via the antispasmodic) and lessens the patient's awareness of the resulting pain (via the analgesic). This strategic combination helps restore comfort and function by addressing both symptoms at once for conditions presenting with acute spasmodic discomfort. The medication is meant to tackle discomfort rooted in muscle tightening.

Advertisements

What side effects are possible with Escapin Compuesto?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse reactions for Escapin Compuesto based on its dual active ingredients: the antispasmodic Hyoscine Butylbromide and the analgesic Acetaminophen. The safety profile is structured by frequency and the physiological system affected.

Adverse Reactions by Frequency

Reactions linked primarily to the antispasmodic component's anticholinergic properties are commonly reported. These include dry mouth and accommodation disorders (difficulty focusing vision). Uncommon adverse reactions include tachycardia (increased heart rate), skin reactions (such as urticaria or pruritus), and dyshidrosis (abnormal sweating). Urinary retention is classified as a rare effect.

Serious Adverse Reactions and Systemic Risks

The most significant risks documented in official labeling include rare, severe hypersensitivity reactions, notably anaphylactic shock, and severe skin reactions (SCARs), such as Stevens-Johnson Syndrome. The Acetaminophen component carries a specific safety risk for hepatotoxicity (liver damage), which is a major concern, particularly with excessive or prolonged exposure.

Safety-Related Restrictions

Use of Escapin Compuesto is formally restricted (contraindicated) in several pre-existing conditions, including narrow-angle glaucoma, prostate hypertrophy with urinary retention, and specific conditions causing gastrointestinal obstruction, such as mechanical stenosis, paralytic ileus, and megacolon. Caution is also advised for patients with pre-existing impaired liver or kidney function or certain cardiac conditions.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Escapin Compuesto presents a dual risk profile due to its active components, Acetaminophen and Hyoscine Butylbromide. Official regulatory documents mandate seeking immediate medical attention or contacting a Poison Control Center right away, even if no symptoms are present, as the most severe outcome, acute liver failure, can be delayed. Immediate medical advice is required if severe, unexplained abdominal pain persists or occurs alongside signs such as fever, fainting, or blood in stool.


Documented Overdose Manifestations

Initial signs of toxicity documented in regulatory sources may include nausea, vomiting, sweating, and pallor, which can progress to life-threatening outcomes such as acute liver failure (hepatotoxicity) and death. The anticholinergic effects of the second component may cause dry mouth, rapid heart rate (tachycardia), confusion, urinary retention, and a documented risk of respiratory paralysis. Increased overdose risk is specifically noted for individuals with underlying liver or kidney disease.


Required Emergency Actions

Official management requires laboratory monitoring of plasma acetaminophen concentration and hepatic function (e.g., AST/ALT). The specific antidote, N-acetylcysteine (NAC), must be administered to mitigate the documented hepatotoxicity risk. Supportive treatment may include activated charcoal and measures like catheterisation for specific anticholinergic effects, as detailed in official regulatory prescribing information.

Advertisements

Therapeutic Uses of Escapin Compuesto

What Escapin Compuesto Treats: Main Uses and Benefits

The main uses and benefits of Escapin Compuesto involve managing symptoms related to physical discomfort linked to organ-specific functional stress. The formulation is commonly used across conditions characterized by episodic or fluctuating manifestations within key systems. For instance, the combination may be part of symptomatic management for easing spastic pain and functional disorders in the gastrointestinal and biliary tracts, the urinary tracts, and the female genital organs, particularly dysmenorrhea.

The medicine is applied across domains where additional symptomatic support is needed, applied in clinical settings that involve acute or unstable symptom patterns. When groups of symptoms appear suddenly or fluctuate, the combination generally offers symptomatic relief that helps patients cope more steadily with symptom fluctuations. This support is also relevant when symptoms related to systemic imbalance, such as fever, are present alongside the primary discomfort.

“This combination may provide support that helps ease the overall symptom burden during phases when symptoms become more noticeable.”


Quick Fact: Relief for Combined Pain and Spasm

Feature Therapeutic Context
Symptom Cluster Symptoms that interfere with daily functioning, linked to spasm and pain.
Associated Therapeutic Areas Gastrointestinal, biliary, urinary, and female reproductive tracts.
Patient Benefit Contributes to improved comfort and may assist with maintaining functional stability.

Regulatory References

  1. Indonesian National Agency of Drug and Food Control (BPOM) Product Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Escapin Compuesto?

This section outlines the official eligibility and contraindication status for Escapin Compuesto based on regulatory documents. It is crucial to review these constraints before use.

Escapin Compuesto is contraindicated (must not be used) in patients with a known hypersensitivity to any of its active components or excipients. Formal contraindications also apply to individuals with certain severe underlying conditions, which typically include severe hepatic impairment and severe renal impairment where elimination of the drug may be compromised, leading to toxicity.

Usage is restricted and requires special consideration in several populations. It is generally not recommended for use in pediatric populations (e.g., children under 12 years of age) unless specifically directed by a specialist, as safety and efficacy may not be formally established.

Pregnancy and Lactation: Use during pregnancy is typically restricted, especially during the first and third trimesters, often categorized as contraindicated or not recommended due to potential fetal risks. Similarly, use during lactation is often not recommended as components may pass into breast milk.

Eligibility Status Description (Based on Regulatory Labeling)
Contraindicated Known hypersensitivity to any ingredient; Severe hepatic or renal impairment.
Not Recommended Pediatric patients (e.g., under 12 years old); Pregnancy; Breastfeeding.

Important Note: Escapin Compuesto is intended only for individuals who meet the official eligibility criteria and have no formal contraindications. Consult a healthcare provider for a complete review of your eligibility profile.

Advertisements

What should I know about interactions with other medicines?

The interaction profile for Escapin Compuesto is determined by the combined actions of its two active components, Acetaminophen and Hyoscine Butylbromide, based strictly on authoritative government regulatory documentation.

Documented Interaction Classifications

Additive Pharmacodynamic Effects

Co-administration with other anticholinergic agents, such as tricyclic antidepressants, antihistamines, or certain antipsychotics, is officially documented to result in an intensification of the Hyoscine Butylbromide component's anticholinergic effect. Conversely, agents like Metoclopramide or Domperidone may lead to a diminution of the antispasmodic effect on the gastrointestinal tract.

Pharmacokinetic and Exposure Changes

Substances that accelerate metabolism, such as Phenobarbital and other anti-epileptics, may increase the hepatotoxic potential of Acetaminophen. Other medicines, such as Probenecid, alter Acetaminophen excretion, a constraint that regulatory labels state necessitates a dose reduction of the analgesic component. Oral anticoagulants like Warfarin may also experience an officially documented increased anticoagulant effect when co-administered.

Restrictions and Contraindications

The medicine is contraindicated for use with any other product containing Acetaminophen due to the risk of exceeding the maximum safe dose and causing severe liver damage. Alcohol consumption, particularly three or more drinks daily, is associated with a heightened risk of this severe liver damage. Regulatory information also notes that patients with pre-existing hepatic impairment have an officially recognized increased risk of toxicity from the Acetaminophen component.

Advertisements

Mechanism of Action

️ How Escapin Compuesto Works

Modulating Peripheral Visceral Muscle Tone

This mechanism is defined by the action of Hyoscine Butylbromide, which operates by acting as a competitive antagonist at muscarinic receptors on peripheral smooth muscle. By blocking the signal from the neurotransmitter acetylcholine, this process interrupts the involuntary signaling cascade that leads to muscle contraction. The resulting physiological effect is the relaxation of the smooth muscle tissue. This action modulates the state of hypermotility and is restricted to peripheral pathways due to the molecule’s physiochemical properties.

Dampening Central Nociceptive Signals

The second component, Acetaminophen, engages a multi-target mechanism primarily within the Central Nervous System (CNS). Its activity involves the selective inhibition of the COX pathway (limiting prostaglandin PGE2 synthesis) and the modulation of TRPV1 and CB1 receptors by its metabolite AM404. This interference modulates the activity of central pain pathways, influencing nociceptive signal transmission. The mechanism demonstrates poor inhibition of COX enzymes in peripheral tissues.

Coordinated Dual-Pathway Mechanism

The function involves the coordinated activity of the peripheral antimuscarinic mechanism and the central analgesic mechanism. This dual-pathway mechanism simultaneously modulates peripheral smooth muscle tone and central nociceptive signal transmission.

Advertisements

Dosage and Administration Information

How to Use Escapin Compuesto

Administration of Escapin Compuesto, a fixed-dose combination of Paracetamol and Hyoscine Butylbromide, follows established guidelines for proper use.


Official Administration Guidelines

The medicine is intended for oral administration only. The dosage regimen defines the maximum intake and duration of use, which must be followed precisely.

Instruction Category Official Guideline
Route of Administration Oral only, as a tablet.
Adult Dosing (per dose) 1 to 2 tablets per single administration.
Dosing Frequency Administered up to 3 times daily.
Maximum Daily Dose Total intake must not exceed 6 tablets in 24 hours.

Procedural and Time-Based Constraints

The tablets must be swallowed whole with an adequate amount of liquid and should not be chewed or crushed.

Regarding the duration of treatment, the medicine is generally for short-term use. It should not be taken for a prolonged period, specifically more than 3 days, without consulting a healthcare professional.

In the event of a missed dose, the user is instructed to skip the missed dose if it is near the time for the next scheduled intake, and to not double the dose to compensate.

Population-Specific Rules

Escapin Compuesto is not suitable for children under 10 years of age. Furthermore, high-level caution is advised for its use in patient populations with known impaired kidney or liver function.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Escapin Compuesto

This overview describes the types of clinical research conducted on the combination of Acetaminophen and Hyoscine Butylbromide (Escapin Compuesto), what these studies examined, and where research remains limited, based on authoritative scientific and regulatory sources.


Evidence for Use in Crampy Abdominal Pain

Research has examined Escapin Compuesto in studies of individuals experiencing recurrent crampy abdominal pain. The evidence includes Randomized Controlled Trials (RCTs) and double-blind studies where participants were observed under specific, controlled conditions. These studies were used in research exploring how symptoms change over time and measuring how outcomes related to physical discomfort changed in the short term. The fixed-dose combination was studied for its impact compared to a placebo and, in some cases, compared to taking each active ingredient alone.

Follow-up durations were limited in these initial trials. The comparative evidence is lacking when trying to understand how this combination was evaluated against other treatments studied for abdominal discomfort. Also, the results apply only to the populations studied.


Evidence for Use in Menstrual Cramps (Dysmenorrhea)

Research has examined this combination in studies of women with menstrual cramps, a condition characterized by fluctuating or episodic manifestations. Crossover trials and patient surveys were applied in studies involving women of reproductive age experiencing primary dysmenorrhea. Studies monitored patient-reported outcomes describing perceived discomfort and outcomes reflecting daily functioning during the painful episodes.

Data show patterns related to what was observed when the combination was studied against placebo and the individual components. However, the available evidence is primarily focused on acute, short-term relief, and there is limited information for long-term outcomes regarding the use of this medicine for recurrent menstrual pain over many cycles.


What is Still Uncertain About Escapin Compuesto Research

While research describes the specific study designs and short-term changes observed in acute settings, certainty remains low in several important areas. The evidence base is primarily focused on research scenarios related to acute symptom patterns for temporary conditions.

Key uncertainties include that there is limited information for long-term outcomes due to limited follow-up durations. Comparative evidence is lacking against a wider range of alternative treatments for chronic or recurrent pain conditions, and data for certain groups, such as older adults with specific comorbidities, remain insufficient.

Key Studies & References

  1. Assessment Report and Product Information for Hyoscine Butylbromide/Acetaminophen Combination (BPOM, Indonesia)
  2. Systematic Review of Randomized Controlled Trials (RCTs) on Hyoscine Butylbromide for Acute Abdominal Pain
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Escapin Compuesto (FAQ)

Q: How is Escapin Compuesto different from other common medicines with a similar name?

Escapin Compuesto is described in official documents as a fixed-dose combination product. This means it contains two distinct active ingredients in a single tablet: Acetaminophen (a pain reliever) and Hyoscine Butylbromide (an antispasmodic). This dual composition is what differentiates it from many similar-sounding medicines that contain only one active component.


Q: Are there any long-term effects associated with using Escapin Compuesto?

Regulatory documents specify that this medicine is intended for short-term use only, such as for no more than three days without professional consultation. The available research evidence cited in official sources is primarily focused on demonstrating acute, short-term outcomes related to pain and spasm relief. Information on the effects of prolonged use remains limited.


Q: Does Escapin Compuesto cause drowsiness or affect alertness?

The official product information notes that the Hyoscine Butylbromide component may cause side effects such as dizziness or accommodation disorders (difficulty focusing vision). These side effects are generally noted in the official guidance as potentially impairing the ability to react or focus.


Q: What kind of interactions does Escapin Compuesto have with common over-the-counter medicines?

A critical safety warning in regulatory documents is the contraindication against using this medicine with any other product containing Acetaminophen to avoid exceeding safe dose limits. Official sources also document interactions with medicines that affect gut movement, such as certain common anti-nausea agents, or medicines with anticholinergic properties, like some antihistamines.


Q: Is Escapin Compuesto generally considered safe for older adults?

Caution is generally advised for use in older adults. This is because the anticholinergic component of the medicine can potentially cause or worsen certain conditions, such as urinary retention or increased heart rate (tachycardia), which are noted in official warnings.


Q: Are there any specific safety warnings related to driving or operating machinery when using Escapin Compuesto?

Official guidance advises that if a user experiences side effects like visual disturbances or dizziness after taking the medicine, official guidance generally advises against driving or operating potentially hazardous machinery if those side effects occur. This warning is in place to reduce the risk of accidents related to impaired vision or reaction time.


Q: What does official research indicate about the effectiveness of Escapin Compuesto for its labeled uses?

Clinical research, including Randomized Controlled Trials, has been conducted to examine the effectiveness of the medicine for its approved indications. These studies provided the evidence for its use in reducing symptoms of crampy abdominal pain and menstrual cramps (dysmenorrhea).


Q: How is the safety of Escapin Compuesto generally described in official sources?

The medicine's safety profile is defined by known side effects and contraindications detailed in official documents. The most serious warnings relate to the risk of severe liver damage (hepatotoxicity) from the Acetaminophen component and the potential for rare, severe hypersensitivity reactions like anaphylaxis.


Q: Is Escapin Compuesto available without a prescription in some places?

The regulatory status of this medicine can vary significantly by region. In certain countries, the formulation is available as a pharmacy-only medicine (OTC) for sale without a doctor’s prescription. However, in other locations, it is classified as a prescription-only medicine (Rx).


Q: Is it normal to feel a mild stomach upset after taking Escapin Compuesto?

Common gastrointestinal issues like stomach upset are not listed among the most frequently reported side effects in official documents. Adverse reactions are classified by frequency, and only uncommon or rare gastrointestinal effects may be documented in the full product information.


Q: What are some common misunderstandings about the purpose of Escapin Compuesto?

Official documents define the use of Escapin Compuesto for pain associated with smooth muscle spasms. A common misunderstanding may be confusing it with a single-ingredient medicine or expecting it to treat general pain not caused by a spasm.


Q: Do official documents mention any potential for dependence with Escapin Compuesto?

Regulatory labeling does not typically classify this medicine as having a risk of physical dependence or addiction. This is based on the determination that its two active components do not possess the abuse potential associated with controlled substances.


Q: Can Escapin Compuesto affect the results of certain medical tests?

Yes, the Acetaminophen component of the medicine has been associated with potential interference in certain laboratory results. Specifically, official warnings note that it may affect the measurements for uric acid and blood glucose tests.


Q: Does Escapin Compuesto contain common allergens like gluten or lactose?

Information regarding the inactive ingredients, known as excipients, is documented in the full prescribing information. The presence of common inactive ingredients, such as lactose or starch derivatives, can be confirmed in this section.


Q: Is there any research evidence on Escapin Compuesto being studied for new uses?

Regulatory evidence focuses strictly on the medicine's approved indications for crampy pain and spasms. While information regarding studies for new or exploratory uses may be found in public clinical trial registries, the official drug labeling only supports the established uses.


Q: Can Escapin Compuesto be taken on an empty stomach?

The official administration guidelines instruct users to swallow the tablets with an adequate amount of liquid. The documents typically do not contain an explicit instruction on whether the medicine must be taken with or without food.


Q: What is the guidance on accidental overdose of Escapin Compuesto?

Official documents state that an overdose of this medicine is considered a medical emergency because the Acetaminophen component can lead to severe liver damage. Official regulatory guidance mandates that in the event of an overdose, prompt consultation with a healthcare professional or emergency services should be sought.


Q: Is Escapin Compuesto considered a narcotic or controlled substance?

Escapin Compuesto is generally not classified as a narcotic or controlled substance under most international regulatory frameworks. This is based on the determination that the active components do not have abuse potential at therapeutic doses.


Q: What does the research say about how quickly Escapin Compuesto starts working?

Clinical research data used in regulatory submissions generally includes details on the medicine’s effectiveness in relation to time. This information describes the medicine's onset of action to characterize how rapidly it provides relief for acute symptoms.


Q: How long can the effects of Escapin Compuesto typically be expected to last?

The effects of the medicine are described to last long enough to support the official dosing frequency, which is consistent with the recommended dosing interval. Pharmacokinetic data available to regulatory bodies defines the half-life of the active components, which informs the recommended dosing interval.


Q: Is the onset of effect for Escapin Compuesto described as gradual or sudden?

Based on its indication for acute spasmodic discomfort, the relief is generally described in official summaries in relation to the medicine's rapid onset of action. This rapid onset profile is suitable for addressing sudden and temporary cramping pain.


Q: What is the general expectation for improvement when using Escapin Compuesto?

The general expectation defined by regulatory documents is to achieve short-term symptomatic relief from pain that is caused by smooth muscle spasms. The medicine is not intended for chronic use or to cure underlying conditions.


Q: Can Escapin Compuesto be used by people with a history of stomach ulcers?

While a history of stomach ulcers is not listed as a formal contraindication, the official guidance lists specific contraindications for gastrointestinal obstructions. Caution is generally advised for conditions where the anticholinergic effects of the medicine could potentially be detrimental.


Q: Does the medicine label for Escapin Compuesto include a Black Box Warning?

Yes, the medicine label for all Acetaminophen-containing products sold in the United States, including Escapin Compuesto, is required by the FDA to include a Black Box Warning. This prominent warning highlights the risk of severe liver failure and serious skin reactions.

Advertisements

How should Escapin Compuesto be stored and disposed of?

The storage and disposal of Escapin Compuesto must strictly adhere to the conditions specified in its official regulatory labeling to ensure product stability and safety.

Official Storage Requirements

Condition Requirement
Temperature Store at a controlled room temperature (e.g., below 30 C); do not freeze or refrigerate.
Protection Protect from light and moisture; keep the packaging tightly closed in the original container.
Safety Must be kept out of the sight and reach of children to prevent accidental ingestion.
Stability Do not use the medicine after the expiration date printed on the package.

️ Disposal Instructions

Unused or expired Escapin Compuesto must be disposed of according to local regulations. It is prohibited to dispose of the medicine via wastewater or the sewage system. Disposal should involve an approved drug take-back program or, if unavailable, secure household disposal (such as mixing with an unappealing substance and placing it in a sealed container before discarding).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Escapin Compuesto found in:

A-Z Index: